Table 1.
Psychometric data of the study population
| Untreated patients (N = 69) |
Treated patients | ||||
|---|---|---|---|---|---|
| Satisfied with the actual treatment (N = 35) |
Dissatisfied with the actual treatment | ||||
| Augmentation (N = 19) | Loss of efficacy (N = 35) |
Side effects (N = 8) |
|||
| IRLS | 24.0 (8.8) | 26.9 (5.6) | 31.4 (4.1)** | 31.6 (5.9)*** | 27.1 (5.8) |
| BDI-II | 11.3 (8.9) | 12.0 (8.4) | 15.8 (8.3)* | 16.1 (10.3)* | 11.9 (5.4) |
| SCL-90-R | |||||
| GSI | 0.7 (0.6) | 0.7 (0.5) | 1.0 (0.6)* | 0.9 (0.6) | 0.6 (0.3) |
| Somatisation | 0.9 (0.6) | 0.9 (0.6) | 1.2 (0.6)* | 1.2 (1.1) | 0.8 (0.4) |
| Compulsivity | 0.8 (0.7) | 0.8 (0.8) | 1.2 (0.8)* | 1.2 (0.9)* | 0.9 (0.4) |
| Insecurity in social contact | 0.8 (2.7) | 0.6 (0.6) | 0.9 (0.6)* | 06. (0.6) | 0.5 (0.5) |
| Depression | 0.7 (0.8) | 0.8 (0.8) | 1.0 (0.8) | 1.0 (0.8)* | 0.8 (0.4) |
| Anxiety | 0.6 (0.1) | 0.7 (0.5) | 0.9 (0.6)* | 0.8 (0.6) | 0.4 (0.3) |
| Hostility | 0.4 (0.5) | 0.5 (0.5) | 0.8 (0.6)** | 0.6 (0.7) | 0.4 (0.3) |
| Phobic anxiety | 0.4 (0.6) | 0.2 (0.4) | 0.5 (0.7) | 0.5 (0.6)* | 0.2 (0.2) |
| Paranoid ideation | 0.4 (0.5) | 0.4 (0.5) | 0.8 (0.7)** | 0.6 (0.6) | 0.3 (0.2) |
| Psychoticism | 0.4 (0.7) | 0.3 (0.7) | 0.6 (1.0) | 0.4 (0.5) | 0.2 (0.2) |
*: p < 0.05; **: p < 0.01; ***: p < 0.001
Raw scores of sub-scales and Global Severity Index (GSI) of the SCL-90-R are presented. Values are mean (SD). Statistically significant results refer to comparisons of each group with untreated patients.